CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-13 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Options (Right to Buy) | −20,000 | 67,983 | ||
| 2017-11-13 | El-Hibri Fuad Chairman | Sale | −20,000 | $40.69 | $814K | 1,510,216 |
| 2017-11-08 | Zoon Kathryn C Director | Sale | −2,371 | $38.94 | $92K | 20,114 |
| 2017-11-08 | Zoon Kathryn C Director | Sale | −371 | $40.84 | $15K | 19,743 |
| 2017-11-07 | JOULWAN GEORGE A Director | Exercise or conversion | +3,946 | $15.97 | $63K | 34,323 |
| 2017-11-07 | JOULWAN GEORGE A Director | Sale | −3,946 | $41.24 | $163K | 30,377 |
| 2017-11-07 | JOULWAN GEORGE A Director | Exercise or conversion | +10,305 | $18.64 | $192K | 40,682 |
| 2017-11-07 | JOULWAN GEORGE A Director | Sale | −10,305 | $41.24 | $425K | 30,377 |
| 2017-11-07 | JOULWAN GEORGE A Director | Exercise or conversion · Employee Stock Option (Right to buy) | −3,946 | 0 | ||
| 2017-11-07 | JOULWAN GEORGE A Director | Exercise or conversion · Employee Stock Option (Right to buy) | −10,305 | 0 | ||
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Exercise or conversion | +11,508 | $22.03 | $254K | 215,642 |
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Sale | −11,508 | $42.50 | $489K | 204,134 |
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Exercise or conversion | +20,000 | $14.44 | $289K | 224,134 |
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Sale | −20,000 | $42.92 | $858K | 204,134 |
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −11,508 | 0 | ||
| 2017-11-03 | Abdun-Nabi Daniel President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 41,906 | ||
| 2017-09-29 | El-Hibri Fuad Chairman | Sale | −25,000 | $40.50 | $1.0M | 1,530,216 |
| 2017-09-28 | Richard Ronald Director | Exercise or conversion | +22,415 | $7.99 | $179K | 45,825 |
| 2017-09-28 | Richard Ronald Director | Sale | −22,415 | $40.00 | $897K | 23,410 |
| 2017-09-28 | Richard Ronald Director | Exercise or conversion · Employee Stock Option (Right to buy) | −22,415 | 0 |
Page 43 of 45 · 887 trades